US: 1.917.963.8646 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Doxorubicin is a kind of antitumor antibiotics, can inhibit the synthesis of RNA and DNA, RNA in the strongest inhibitory effect. Doxorubicin has an effect on a wide variety of tumor, belongs to the cycle non-specific drug, have all sorts of growth cycle of tumor cells to kill.it's given by injection into a vein. The global Doxorubicin market is valued at 910 million US$ in 2018 is expected to reach 1410 million US$ by the end of 2025, growing at a CAGR of 5.6% during 2019-2025. This report focuses on Doxorubicin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Doxorubicin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Sun Pharmaceuticals Pfizer Cipla Cadila Pharmaceuticals SRS Pharmaceuticals ... Segment by Regions North America Europe China Japan Segment by Type Lyophilized Powder Doxorubicin Injection Segment by Application Ovarian Multiple Myeloma Kaposi Sarcoma Leukemia Bone Sarcoma Breast Gastric Liver Kidney
Table of Contents Executive Summary 1 Doxorubicin Market Overview 1.1 Product Overview and Scope of Doxorubicin 1.2 Doxorubicin Segment by Type 1.2.1 Global Doxorubicin Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Lyophilized Powder 1.2.3 Doxorubicin Injection 1.3 Doxorubicin Segment by Application 1.3.1 Doxorubicin Consumption Comparison by Application (2014-2025) 1.3.2 Ovarian 1.3.3 Multiple Myeloma 1.3.4 Kaposi Sarcoma 1.3.5 Leukemia 1.3.6 Bone Sarcoma 1.3.7 Breast 1.3.8 Gastric 1.3.9 Liver 1.3.10 Kidney 1.4 Global Doxorubicin Market by Region 1.4.1 Global Doxorubicin Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Doxorubicin Market Size 1.5.1 Global Doxorubicin Revenue (2014-2025) 1.5.2 Global Doxorubicin Production (2014-2025) 2 Global Doxorubicin Market Competition by Manufacturers 2.1 Global Doxorubicin Production Market Share by Manufacturers (2014-2019) 2.2 Global Doxorubicin Revenue Share by Manufacturers (2014-2019) 2.3 Global Doxorubicin Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Doxorubicin Production Sites, Area Served, Product Types 2.5 Doxorubicin Market Competitive Situation and Trends 2.5.1 Doxorubicin Market Concentration Rate 2.5.2 Doxorubicin Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Doxorubicin Production Market Share by Regions 3.1 Global Doxorubicin Production Market Share by Regions 3.2 Global Doxorubicin Revenue Market Share by Regions (2014-2019) 3.3 Global Doxorubicin Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Doxorubicin Production 3.4.1 North America Doxorubicin Production Growth Rate (2014-2019) ... | read more...